In vitro

mRNA
#In vitro #mRNA #Whitepaper

Whitepaper: Explore a new approach to IVT capping

Download this new Whitepaper from Aldevron to learn about a novel RNA polymerase designed to support high-quality mRNA production. Supports co-transcriptional capping during in vitro transcription (IVT) Designed to work efficiently with commercially available cap analogs Helps researchers generate high-quality mRNA transcripts Access the full Whitepaper to explore IVT capping… Read More

#News

#Animal models #In vitro #Innovate UK #UK government

Initiative aims to replace animal models for drug development 

A new UK initiative is aiming to transform human-based research models to provide better understanding of disease and accelerate new medicines.   The UKRI Medical Research Council (MRC), Wellcome and UKRI Innovate UK committed a joint £15.9 million ($20.9 million) investment to develop advanced, specific and highly reproducible… Read More

#Editor's Choice #News

Antibody drug conjugate
#Antibody drug conjugate (ADC) #In vitro #In vivo

Navigating considerations for ADCs: Guidance for the industry

This paid-for advertorial from Eurofins appeared in DDW Volume 26 – Issue 4, Fall 2025   Antibody-drug conjugates (ADCs) are increasingly promising due to advances in biologics and chemistry. With 16 FDA-approved ADCs, clinical interest is growing, though development remains complex, requiring thorough evaluation of the antibody, linker, payload, and… Read More

#Exclusive Content

Circular DNA concept
#Cell and gene therapy #Circio Holding #circular RNAs #In vitro #In vivo

Circular RNA technology could open new therapeutic opportunities

Circular RNA technology continues to demonstrate broad capability to significantly boost protein expression level and durability for both viral and non-viral gene and cell therapy, according to new data.  Circio Holding shared the new and strengthened in vivo data for its circVec platform at the… Read More

#News

TEM micrograph of kidney proximal tubule cells
#Drug development #Drug discovery #Drug toxicity #eBook #In vitro #In vitro assays

eBook: A guide to predictive in vitro renal proximal tubule models

This latest eBook provides a comprehensive guide to predictive in vitro renal proximal tubule models for safety, efficacy and transporter studies. The Newcells Renal Proximal Tubule Cells Model eBook covers topics including: Cross-species comparison of drug handling Transporter mediated drug-drug interactions Drug-induced renal toxicity New drug modalities e.g. RNA therapeutics… Read More

#News

#Drug development #Drug discovery #Drug toxicity #In vitro #In vitro assays

Your comprehensive guide to predictive in vitro renal proximal tubule models for safety, efficacy and transporter studies

The Newcells Renal Proximal Tubule Cells Model eBook covers topics including: Cross-species comparison of drug handling Transporter mediated drug-drug interactions Drug-induced renal toxicity New drug modalities e.g. RNA therapeutics and how to measure mitochondrial health… Read More

#Resources

Red blood cells
#Assays #Cellular imaging #Drug discovery #High throughput screening #In vitro #Technical Note

Technical Note: Unlocking high-throughput potential

A new Technical Note from Lonza is now available entitled ‘Primary Human Umbilical Vein Endothelial Cells: A Qualitative, Real-time, In-vitro Tube Formation Assay‘. Download the Technical Note to learn more about these unique features: Co-culture model with high biological relevance Compatible with live-cell imaging which allows for real-time… Read More

#News

#App note #CNS #In vitro #In vitro assays #iPSC #Neuroscience

App Note: Optimisation for a live cell in vitro neuronal activity assay

Human induced pluripotent stem cell (iPSC) derived models are increasingly being used for in vitro studies of the human central nervous system. Growth factors and cytokines are critical in these models for cell growth, differentiation, and survival, but their study is complicated by factors like unknown commercial media compositions and… Read More

#News

#In vitro #In vitro assays #iPSC #Neuroscience

Development of robust co-culture models with human iPSC-derived microglia and excitatory neurons

Download this Application Note to learn more about: Co-culture methods for ioMicroglia with wild type and disease model ioGlutamatergic Neurons. Assay optimisation for a live cell in vitro neuronal activity assay. Solutions for visualisation and quantification of changes in co-culture health, morphology, function and marker expression. Read More

#Resources

#ADME / Tox #Human disease models #In vitro #iPSC #Toxicology #Webinar

Learn how to better replicate liver functionality for toxicology testing

A new event ‘Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro’ is now open for registrations. The webinar, hosted by DDW and supported by bit.bio, will take place on 3 December 2024 at 4pm GMT. In his talk,… Read More

Webinar date:
Supported by bit.bio
#News

Human liver
#ADME / Tox #Human disease models #In vitro #iPSC #Toxicology #Webinar

Advancements in in vitro modelling for human liver toxicity

A new event ‘Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro’ is now open for registrations. The webinar, hosted by DDW and supported by bit.bio, will take place on 3 December 2024 at 4pm GMT. In his talk,… Read More

Webinar date:
Supported by bit.bio
#News

Human liver
#ADME / Tox #Human disease models #In vitro #iPSC #Toxicology #Webinar

Register now: Discover human iPSC-derived hepatocytes for drug discovery

A new event ‘Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro’ is now open for registrations. The webinar, hosted by DDW and supported by bit.bio, will take place on 3 December 2024 at 4pm GMT. In his talk,… Read More

Webinar date:
Supported by bit.bio
#News

#ADME / Tox #Human disease models #In vitro #iPSC #Toxicology #Webinar

Webinar: Overcome common pitfalls in in vitro modelling for liver toxicity

A new event ‘Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro’ is now open for registrations. The webinar, hosted by DDW and supported by bit.bio, will take place on 3 December 2024 at 4pm GMT. In his talk,… Read More

Webinar date:
Supported by bit.bio
#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

New webinar showcases cutting-edge tools for drug discovery

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids #Webinar

Webinar: Complex in vitro models and AI-powered 3D/4D image analysis

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA)… Read More

Webinar date:
Supported by Zeiss
#News